Your browser doesn't support javascript.
loading
Specific Gene Co-variation Acts Better Than Number of Concomitant Altered Genes in Predicting EGFR-TKI Efficacy in Non-small-cell Lung Cancer.
Zhu, Yan-Juan; Qu, Xin; Zhan, Dan-Dan; Chen, Hui-Hui; Li, Hai-Peng; Liu, Li-Rong; Chen, Xian; Liu, Yi-Hong; Li, Yong; Bai, Jian-Ping; Ye, Sheng; Zhang, Hai-Bo.
Afiliação
  • Zhu YJ; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
  • Qu X; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
  • Zhan DD; Department of Oncology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Chen HH; Department of Oncology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China; Department of Gynecology, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Zhuhai, China.
  • Li HP; Department of Oncology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China; Area 7 of Tumor Chemotherapy Department, Central Hospital of Guangdong Nongken, Zhanjiang, China.
  • Liu LR; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
  • Chen X; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
  • Liu YH; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
  • Li Y; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
  • Bai JP; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
  • Ye S; Department of Oncology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Zhang HB; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine
Clin Lung Cancer ; 22(1): e98-e111, 2021 01.
Article em En | MEDLINE | ID: mdl-33067127

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Neoplasias Pulmonares / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Neoplasias Pulmonares / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China